Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-10
1998-10-27
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, A61K 3140, A61K 3135
Patent
active
058278737
ABSTRACT:
The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders.
REFERENCES:
patent: 4447622 (1984-05-01), Salman et al.
patent: 5554601 (1996-09-01), Simpkins et al.
Ray et al., "An X-ray Crystallographic Study of the Nonsterodial Contraceptive Agent Centchroman", J. Med. Chem. Soc., vol. 37, pp. 696-700. (1994).
Guldhammer Birgitte Hjort
Korsgaard Niels
Shalmi Michael
Agris Cheryl
Criares Theodore J.
Novo Nordisk A S
Zelson Steve T.
LandOfFree
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1614177